Hyong Kim
CIK 1993255 · Chief Medical Officer · last filed 2026-06-15
Hyong Kim is a Chief Medical Officer who has filed 36 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing shows the insider sold $713.9K of ALHC on Jun 15, 2026. Across all open-market trades the lifetime net is −$6.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.93M
1
36
-$6.35M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALHC | Chief Medical Officer | 331,750 | $14.85 | $4.93M | -$6.35M | 19 | 2026-06-15 |
Recent Filings
36 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | ALHC | Sell (S) | −35,951 | -$713.9K | EDGAR |
| 2026-06-12 | ALHC | Notice (144) | −35,951 | -$727.6K | EDGAR |
| 2026-03-19 | ALHC | Sell (S) | −18,404 | -$328.3K | EDGAR |
| 2026-03-17 | ALHC | Grant (A) | +52,972 | $0 | EDGAR |
| 2026-03-16 | ALHC | Notice (144) | −38,762 | -$658.6K | EDGAR |
| 2026-01-06 | ALHC | Notice (144) | −16,506 | -$346.6K | EDGAR |
| 2026-01-06 | ALHC | Sell (S) | −16,506 | -$352.4K | EDGAR |
| 2025-12-30 | ALHC | Sell (S) | −12,694 | -$237.9K | EDGAR |
| 2025-12-23 | ALHC | Notice (144) | −13,000 | -$262.5K | EDGAR |
| 2025-10-10 | ALHC | Sell (S) | −85,034 | -$1.48M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.